The global cancer vaccines market is advancing with personalized mRNA vaccines, neoantigen targeting, and AI-driven development. Therapeutic vaccines dominate, driven by rising cancer prevalence and immunotherapy innovations, with North America leading due to robust research infrastructure.
Cancer Vaccines Market Size & Share | Forecast [2033]
The global cancer vaccines market size reached USD 7.6 Billion in 2024 and grow at a CAGR of 9.73% to reach USD 19.1 Billion by 2033.
https://www.imarcgroup.com/cancer-vaccines-market
11:54 AM - May 28, 2025 (UTC)
